• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $HLF

    Herbalife Ltd.

    Subscribe to $HLF
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. It offers weight management products, including meal replacement products, protein shakes, drink mixes, weight loss enhancers, and healthy snacks; targeted nutrition products, which include functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products comprising N-R-G tea and energy drink products. The company also provides literature, promotional, and other materials that include start-up kits, sales tools, and educational materials. It offers its products through independent service providers and sales representatives, as well as through company-operated retail platforms. The company was formerly known as Herbalife Ltd. and changed its name to Herbalife Nutrition Ltd. in April 2018. Herbalife Nutrition Ltd. was founded in 1980 and is headquartered in Los Angeles, California.

    IPO Year: 2004

    Exchange: NYSE

    Website: herbalife.com

    Recent Analyst Ratings for Herbalife Ltd.

    DatePrice TargetRatingAnalyst
    1/6/2026$20.00Buy
    Maxim Group
    11/26/2025Hold → Buy
    Argus
    3/21/2025$7.50 → $14.00Neutral → Buy
    DA Davidson
    8/1/2024$16.00 → $17.00Buy
    B. Riley Securities
    9/14/2023$13.50Neutral
    DA Davidson
    6/7/2023$13.00Neutral
    Mizuho
    2/3/2023$14.00Underperform
    BofA Securities
    7/12/2022$26.00Hold → Buy
    Jefferies
    5/17/2022Buy → Hold
    Argus
    5/4/2022$60.00 → $26.00Buy → Hold
    Jefferies
    See more ratings

    Herbalife Ltd. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on Herbalife Nutrition with a new price target

    Maxim Group initiated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $20.00

    1/6/26 9:08:50 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by Argus

    Argus upgraded Herbalife Nutrition from Hold to Buy

    11/26/25 7:50:23 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by DA Davidson with a new price target

    DA Davidson upgraded Herbalife Nutrition from Neutral to Buy and set a new price target of $14.00 from $7.50 previously

    3/21/25 8:38:07 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    B. Riley Securities reiterated coverage on Herbalife Nutrition with a new price target

    B. Riley Securities reiterated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $17.00 from $16.00 previously

    8/1/24 8:12:23 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    DA Davidson initiated coverage on Herbalife Nutrition with a new price target

    DA Davidson initiated coverage of Herbalife Nutrition with a rating of Neutral and set a new price target of $13.50

    9/14/23 7:19:53 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Mizuho initiated coverage on Herbalife Nutrition with a new price target

    Mizuho initiated coverage of Herbalife Nutrition with a rating of Neutral and set a new price target of $13.00

    6/7/23 7:55:26 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    BofA Securities initiated coverage on Herbalife Nutrition with a new price target

    BofA Securities initiated coverage of Herbalife Nutrition with a rating of Underperform and set a new price target of $14.00

    2/3/23 7:23:34 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by Jefferies with a new price target

    Jefferies upgraded Herbalife Nutrition from Hold to Buy and set a new price target of $26.00

    7/12/22 9:15:11 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition downgraded by Argus

    Argus downgraded Herbalife Nutrition from Buy to Hold

    5/17/22 9:07:57 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition downgraded by Jefferies with a new price target

    Jefferies downgraded Herbalife Nutrition from Buy to Hold and set a new price target of $26.00 from $60.00 previously

    5/4/22 6:12:06 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cloud Lynda bought $152,490 worth of shares (17,000 units at $8.97), increasing direct ownership by 78% to 38,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/20/25 8:41:01 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    6/9/25 6:00:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/23/25 4:01:25 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $33,650 worth of shares (5,000 units at $6.73) and was granted 21,857 shares, increasing direct ownership by 20% to 161,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/6/25 8:19:33 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $20,000 worth of shares (2,500 units at $8.00), increasing direct ownership by 2% to 135,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    3/6/25 5:11:51 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $41,250 worth of shares (5,000 units at $8.25), increasing direct ownership by 4% to 132,500 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    3/3/25 5:45:46 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $21,225 worth of shares (2,500 units at $8.49), increasing direct ownership by 2% to 127,500 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/13/24 4:44:45 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $39,950 worth of shares (5,000 units at $7.99), increasing direct ownership by 4% to 125,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/5/24 6:33:07 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $71,100 worth of shares (10,000 units at $7.11), increasing direct ownership by 9% to 120,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    9/9/24 6:14:06 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $87,200 worth of shares (10,000 units at $8.72), increasing direct ownership by 10% to 110,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    8/27/24 5:40:07 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Herbalife Named to Three 2026 USA TODAY Most Trusted Brands Lists

    Recognitions reflect consumer confidence in the company's quality, reliability, and wellness leadership across generations Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, has been named to three 2026 USA TODAY Most Trusted Brands lists, including Most Trusted Brands, Brands Most Trusted by Parents, and Brands Most Trusted by Senior Citizens. The recognitions reflect consumer confidence in Herbalife's science-backed products and commitment to supporting healthy, active lifestyles across generations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603147461/en/Herbalife Named to Three

    6/3/26 4:30:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Chief Financial Officer to Present at East Coast IDEAS Conference on June 11

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, will present at the East Coast IDEAS Conference on Thursday, June 11, 2026 at 10:35 a.m. ET (7:35 a.m. PT). The live webcast will be available at the following link: https://event.summitcast.com/view/GAjb2PfaSPbv9ViGy3AtzN/ZC5vwyKUXDsTKS4G6iXFet A link to the webcast will also be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/. A replay of the webcast will be available at the same website following the completion of the event and for six months thereafter. Additional information regarding th

    6/2/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Roman DBDR Acquisition Corp. II Appoints Hunter Gary to Board of Directors and Al Basseri as Chief Technology Officer, Ahead of Proposed Business Combination with ThomasLloyd Climate Solutions

    Roman DBDR Acquisition Corp. II ("Roman DBDR" or the "Company") (NASDAQ:DRDB) today announced the appointment of Hunter Gary to its Board of Directors (the "Board") and Al Basseri as Chief Technology Officer, as the Company continues preparations to complete its previously announced business combination with ThomasLloyd Climate Solutions B.V. ("ThomasLloyd"), a vertically integrated sustainable energy and technology solutions provider (the "Proposed Business Combination"). "We are thrilled to welcome Hunter to the Board of Directors and Al as our Chief Technology Officer as we prepare to complete our business combination with ThomasLloyd," said Dixon Doll, Jr., Chairman and CEO of Roman D

    5/15/26 8:00:00 AM ET
    $AEP
    $CVI
    $DRDB
    Electric Utilities: Central
    Utilities
    Integrated oil Companies
    Energy

    Herbalife and Cristiano Ronaldo Bring Performance Nutrition to Everyday Routines with "Fuel Like Ronaldo" Campaign

    Backed by more than 20 years of experience fueling elite athletes, Herbalife brings its proven performance nutrition expertise to wellness seekers worldwide Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the launch of its "Fuel Like Ronaldo" campaign, a global initiative that translates elite athlete nutrition and performance strategies into practical guidance for everyday wellness seekers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260508653160/en/Herbalife and Cristiano Ronaldo Bring Performance Nutrition to Everyday Routines with "Fuel Like Ronaldo" Campaign. Ba

    5/8/26 7:00:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Reports First Quarter 2026 Net Sales Growth and Adjusted EBITDA1 Above Guidance; Raises Full-Year 2026 Constant Currency2 Net Sales and Adjusted EBITDA1 Guidance Midpoints

    Q1 Results in Line with Preliminary Results Announced on April 14 Herbalife Ltd. (NYSE:HLF) today reported financial results for the first quarter ended March 31, 2026: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506758807/en/ "We delivered strong Q1 results that exceeded guidance and we successfully completed our debt refinancing. At the same time, we took further strategic actions to build on Herbalife's deep-rooted strength in personalization, enhance speed to market capabilities, and position us for long-term growth and value creation." - Stephan Gratziani, CEO Highlights First Quarter 2026 Net sales of $1.3

    5/6/26 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Completes $1.45 Billion Senior Secured Refinancing

    Strategic Refinancing Expected to Result in Approximately $45 Million in Annual Cash Interest Savings1 Herbalife Ltd. (NYSE:HLF) (the "Company"), a premier health and wellness company, community and platform, today announced the closing of the previously announced private offering by HLF Financing SaRL, LLC and Herbalife International, Inc. (together, the "Issuers"), each a wholly owned subsidiary of the Company, of $800 million aggregate principal amount of 7.750% senior secured notes due in May 2033 ("2033 Secured Notes"). Concurrently with the issuance of the 2033 Secured Notes, the Company amended its 2024 senior secured credit facility ("2024 Credit Facility"). The amendments to the

    4/29/26 4:15:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Announces Pricing of $800 Million Aggregate Principal Amount of Senior Secured Notes Offering

    Herbalife Ltd. (NYSE:HLF) (the "Company"), a global health and wellness company, today announced the pricing of the previously announced offering, by HLF Financing SaRL, LLC and Herbalife International, Inc. (together, the "Issuers"), each a wholly owned subsidiary of the Company, of $800 million aggregate principal amount of senior secured notes due 2033 (the "Notes") at a price to the public of 100.00% of par. The Notes have a fixed annual interest rate of 7.750%, which will be paid semi-annually on May 1 and November 1 of each year, commencing on November 1, 2026. The Notes will be guaranteed on a senior secured basis by each of the Company and the Company's existing and future subsidi

    4/15/26 7:02:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Announces Proposed Offering of $800 Million Aggregate Principal Amount of Senior Secured Notes

    Herbalife Ltd. (NYSE:HLF) (the "Company"), a global health and wellness company, today announced that HLF Financing SaRL, LLC and Herbalife International, Inc. (together, the "Issuers"), each a wholly owned subsidiary of the Company, intend, subject to market and other conditions, to offer $800 million aggregate principal amount of senior secured notes due 2033 (the "Notes"). The Company expects to use the net proceeds from the offering, together with proceeds from the refinancing of the Company's existing senior secured credit facility, including borrowings under its revolving credit facility, and available cash, to repay indebtedness, including borrowings outstanding under the Company's

    4/14/26 8:01:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Provides Preliminary Q1 2026 Results: Net Sales Above Guidance, Adjusted EBITDA1 Expected At or Above High End of Guidance; Provides Update on Senior Secured Debt Refinancing Plans

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced preliminary first quarter 2026 results. The Company expects: Net sales growth of 7.5% to 8.0% year-over-year, exceeding the high end of previously issued first quarter guidance Net sales growth on a constant currency basis2 of 5.0% to 5.5% year-over-year, above the high end of previously issued first quarter guidance; and Adjusted EBITDA¹ on a reported basis at or above the high end of previously issued first quarter guidance First quarter 2026 guidance for each metric was previously issued on February 18, 2026. The Company's first quarter net sales outperformance was driv

    4/14/26 8:00:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife to Announce First Quarter 2026 Results on May 6

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its first quarter 2026 financial results after the close of trading on the NYSE on Wednesday, May 6, 2026. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/udjduiru Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BIe9234

    4/1/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Herbalife Ltd. SEC Filings

    View All

    Amendment: New insider Walsh Des claimed ownership of 50,000 shares (SEC Form 3)

    3/A - HERBALIFE LTD. (0001180262) (Issuer)

    5/20/26 8:49:59 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Chief Operating Officer Hicks Troy sold $619,556 worth of shares (48,377 units at $12.81), exercised 83,270 shares at a strike of $9.31 and covered exercise/tax liability with 72,626 shares, decreasing direct ownership by 80% to 9,706 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/20/26 8:50:19 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Chief Commercial Officer Lamberti Frank sold $1,932,259 worth of shares (142,919 units at $13.52), decreasing direct ownership by 80% to 36,624 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/12/26 9:59:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Cloud Lynda was granted 11,879 shares, increasing direct ownership by 31% to 50,736 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/12/26 9:58:56 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Otero Maria was granted 11,879 shares, increasing direct ownership by 14% to 95,129 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/12/26 9:58:44 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Carmona Richard H was granted 11,879 shares, increasing direct ownership by 17% to 83,645 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/12/26 9:58:28 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Levitt Michael J was granted 11,879 shares, increasing direct ownership by 32% to 49,393 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/12/26 9:58:13 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel was granted 11,879 shares, increasing direct ownership by 7% to 181,879 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/12/26 9:57:59 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Walsh Des was granted 11,879 shares, increasing direct ownership by 24% to 61,879 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/12/26 9:57:44 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Macadrai Rodica was granted 11,879 shares, increasing direct ownership by 21% to 67,441 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/12/26 9:57:30 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form 144 filed by Herbalife Ltd.

    144 - HERBALIFE LTD. (0001180262) (Subject)

    5/11/26 4:12:44 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HERBALIFE LTD. (0001180262) (Filer)

    5/6/26 4:28:47 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form 10-Q filed by Herbalife Ltd.

    10-Q - HERBALIFE LTD. (0001180262) (Filer)

    5/6/26 4:23:43 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SCHEDULE 13G filed by Herbalife Ltd.

    SCHEDULE 13G - HERBALIFE LTD. (0001180262) (Subject)

    5/6/26 11:18:37 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Events That Accelerate or Increase a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - HERBALIFE LTD. (0001180262) (Filer)

    5/1/26 4:58:28 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - HERBALIFE LTD. (0001180262) (Filer)

    4/15/26 7:32:33 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - HERBALIFE LTD. (0001180262) (Filer)

    4/14/26 9:40:07 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Herbalife Ltd.

    SCHEDULE 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    3/26/26 11:37:49 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form DEFA14A filed by Herbalife Ltd.

    DEFA14A - HERBALIFE LTD. (0001180262) (Filer)

    3/17/26 4:33:47 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form DEF 14A filed by Herbalife Ltd.

    DEF 14A - HERBALIFE LTD. (0001180262) (Filer)

    3/17/26 4:31:25 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/14/24 4:11:11 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G filed by Herbalife Ltd.

    SC 13G - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 4:01:31 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 12:49:27 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/7/24 1:14:51 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Herbalife Ltd. (Amendment)

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    2/14/24 5:53:54 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Herbalife Ltd. (Amendment)

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    2/14/24 4:00:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Herbalife Ltd. (Amendment)

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    2/13/24 5:06:16 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Herbalife Ltd. (Amendment)

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    2/13/24 10:52:19 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Herbalife Ltd. (Amendment)

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    2/8/24 2:58:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G filed by Herbalife Nutrition Ltd.

    SC 13G - HERBALIFE NUTRITION LTD. (0001180262) (Subject)

    2/14/23 5:05:26 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. Leadership Updates

    Live Leadership Updates

    View All

    Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq

    Transaction accelerates Herbalife and Cristiano Ronaldo's commitment to scale personalized nutrition and wellness globally Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced an agreement to acquire certain assets from Bioniq, a UK-based personalized supplements company focused on making health more accessible and actionable. The transaction advances Herbalife's vision of becoming a technology-enabled, data-driven health and wellness platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326423343/en/Herbalife to Expand Its Personalized Nutritional Supplement Capabilit

    3/26/26 6:30:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Welcomes Lynda Cloud to its Board of Directors

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife's continued commitment to innovation, digital transformation, and personalized wellness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425107883/en/Herbalife Welcomes Lynda Cloud to the Board of Directors Lynda Cloud's decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife's next chapter. Her deep expertise in digital learning, consumer experie

    4/25/25 5:12:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Appoints Stephan Gratziani as Chief Executive Officer

    Current CEO Michael Johnson Transitions to Executive Chairman Herbalife Ltd. (NYSE:HLF) today announced its Board of Directors has appointed President, Stephan Gratziani as Chief Executive Officer (CEO) effective May 1, 2025. Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219653469/en/Herbalife appoints Stephan Gratziani as Chief Executive Officer (Photo: Business Wire) As a former Herbalife independent distributor, Mr. Gratziani built and grew his international business into one of the top global distributorships. For 32 years, he

    2/19/25 4:05:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Expands Board of Directors with Appointment of Perkins Miller

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today welcomed experienced e-commerce and media technology executive Perkins Miller to its board of directors. Miller's appointment as an independent director is effective June 26, 2024. "Perkins brings valuable, proven expertise in leading large-scale e-commerce, technology and sports enterprises, which will be a great asset to our Board as the Company continues to grow and transform," said Michael Johnson, Chairman and CEO of Herbalife. Miller is the CEO of Fandom, the world's largest fan platform where fans immerse themselves in imagined worlds across entertainment and gaming, where he has trans

    6/26/24 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Announces CFO Transition; Initiates Guidance for First Quarter and Full-Year 2024

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the appointment of John DeSimone as Chief Financial Officer, succeeding Alex Amezquita who will remain with the Company. Mr. DeSimone has been an executive at Herbalife for the past 17 years, including more than 8 years as CFO from 2010 – 2018 and 4 years as President and Co-President from 2018 – 2022. Most recently, he served as a Special Advisor to the CEO. "John is a talented and proven finance leader, who has immense experience with Herbalife and a successful track record," said Michael Johnson, Chairman and Chief Executive Officer. "We believe with Stephan Gratziani as President

    3/20/24 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Welcomes Back Michael Levitt to Board of Directors

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, today announced the appointment of veteran finance executive, Michael Levitt, to its Board of Directors, effective March 1, 2024. Levitt previously served on the Company's Board as the Lead Director from 2011 to 2014. Kevin Jones, who has served as a director since 2021, will step down from his role on the Board. "We are honored to welcome Michael back to our Board," said Michael Johnson, Chairman and CEO of Herbalife. "Michael's deep financial expertise, understanding of our business and shared passion for Herbalife's vision will further strengthen our Board." Levitt is the Chairman of Irradiant Partners, LP, an investme

    3/7/24 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Appoints Chief Strategy Officer, Stephan Gratziani, to President

    Herbalife, a premier health and wellness company, today announced the appointment of Stephan Paulo Gratziani to President, effective January 2, 2024, as part of the Company's management succession planning process. Mr. Gratziani will continue to report directly to Chairman and Chief Executive Officer, Michael Johnson. "Stephan hit the ground running and has demonstrated his extensive knowledge of the business and strategic strength in his role as Chief Strategy Officer," said Michael Johnson, Chairman and CEO. "Stephan has an innate ability to lead, drive change and inspire others. We believe his innovative mindset and vast experience as a former leading independent distributor position h

    1/2/24 4:30:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Appoints Former Amway Chief People Officer, Claire V. Groen, to Chief Human Resource Officer

    Herbalife, a premier health and wellness company, announced today that Claire V. Groen has been named the new Chief Human Resource Officer, effective immediately, and is reporting to executive vice president and Chief of Staff, Ibi Montesino. Ms. Groen is the former Chief People Officer at Amway. In this role Ms. Groen is responsible for Herbalife's global human resource strategy and function in support of Herbalife's overall business plan. This includes providing leadership in the areas of employee engagement and culture, talent acquisition and organization design and development, diversity and inclusion, employee relations, leadership development, employee education and training, compen

    10/19/23 9:48:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Appoints Independent Distributor Ms. Rodica Macadrai to Board of Directors

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company today announced, as part of its governance process, the Herbalife Board of Directors has appointed independent distributor, Ms. Rodica Macadrai, as a new member to the Board, effective September 10, 2023. "Rodica will be a valuable addition to our Board, and we look forward to her insight and contributions as an experienced independent distributor in helping guide Board decisions," said Michael Johnson, Chairman and CEO. Ms. Macadrai became an Herbalife independent distributor in 1994 in Moldova, immediately after having earned a Doctor of Medicine in Psychology from Babes Bolyai University in Cluj Napoca, Romania. Over th

    9/14/23 4:40:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Appoints A Top Distributor, Stephan Gratziani, Chief Strategy Officer

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company and community, today announced the appointment of Stephan Paulo Gratziani to Chief Strategy Officer, effective August 4, 2023. Mr. Gratziani will report directly to Chairman and Chief Executive Officer Michael Johnson and work closely with the Company's senior management team to implement and advance key strategic initiatives, including the Herbalife One digital technology platform and business verticals. He will also partner with senior executive and regional leadership to enhance sales training programs, promote distributor engagement, and identify growth opportunities. Mr. Gratziani brings over 32 years of experience to H

    8/2/23 4:09:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. Financials

    Live finance-specific insights

    View All

    Herbalife Reports First Quarter 2026 Net Sales Growth and Adjusted EBITDA1 Above Guidance; Raises Full-Year 2026 Constant Currency2 Net Sales and Adjusted EBITDA1 Guidance Midpoints

    Q1 Results in Line with Preliminary Results Announced on April 14 Herbalife Ltd. (NYSE:HLF) today reported financial results for the first quarter ended March 31, 2026: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506758807/en/ "We delivered strong Q1 results that exceeded guidance and we successfully completed our debt refinancing. At the same time, we took further strategic actions to build on Herbalife's deep-rooted strength in personalization, enhance speed to market capabilities, and position us for long-term growth and value creation." - Stephan Gratziani, CEO Highlights First Quarter 2026 Net sales of $1.3

    5/6/26 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Provides Preliminary Q1 2026 Results: Net Sales Above Guidance, Adjusted EBITDA1 Expected At or Above High End of Guidance; Provides Update on Senior Secured Debt Refinancing Plans

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced preliminary first quarter 2026 results. The Company expects: Net sales growth of 7.5% to 8.0% year-over-year, exceeding the high end of previously issued first quarter guidance Net sales growth on a constant currency basis2 of 5.0% to 5.5% year-over-year, above the high end of previously issued first quarter guidance; and Adjusted EBITDA¹ on a reported basis at or above the high end of previously issued first quarter guidance First quarter 2026 guidance for each metric was previously issued on February 18, 2026. The Company's first quarter net sales outperformance was driv

    4/14/26 8:00:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife to Announce First Quarter 2026 Results on May 6

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its first quarter 2026 financial results after the close of trading on the NYSE on Wednesday, May 6, 2026. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/udjduiru Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BIe9234

    4/1/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments

    Issued on behalf of Doseology Sciences Inc.Equity-Insider.com VANCOUVER, BC, March 5, 2026 /CNW/ -- Consumers are voting with their wallets, and zero-sugar is winning. Zero-sugar beverages are driving 6x more dollar growth than regular varieties as buyers actively choose clean-label products with natural sweeteners and functional ingredients[1]. The global market is forecast to expand from $350 billion in 2024 toward $500 billion by 2029, fueled by health-conscious consumers who want naturally functional products without heavy processing[1]. This structural shift is creating validated demand for precision-dosed, portable formats across energy and wellness categories, positioning Doseology Sc

    3/5/26 9:00:00 AM ET
    $HLF
    $NHTC
    $NMTC
    Other Pharmaceuticals
    Health Care
    Consumer Specialties
    Consumer Discretionary

    Herbalife Delivers Fourth Quarter and Full-Year Net Sales Growth, Net Sales and Adjusted EBITDA1 Exceed Guidance

    Cristiano Ronaldo Invests $7.5 Million in Herbalife's Pro2col™ Technology Herbalife Ltd. (NYSE:HLF) today reported financial results for the fourth quarter and year ended December 31, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218518159/en/ "We exited 2025 with solid momentum, delivering Q4 and full‑year net sales growth and adjusted EBITDA1 above guidance. Cristiano Ronaldo's investment in Pro2col reflects our shared ambition to scale personalized nutrition and wellness globally—uniting science, data, AI, innovation, and community to improve the health and performance of millions." - Stephan Gratziani, CEO Hi

    2/18/26 4:12:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Announces Cristiano Ronaldo Invests $7.5 Million in Pro2col™ Technology, Acquires 10% Equity Stake

    Long-time partner invests in shared vision for personalized health and wellness Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced global sports icon Cristiano Ronaldo acquired a 10% equity interest in HBL Pro2col Software, LLC, an indirect wholly-owned subsidiary of Herbalife that holds the Pro2col technology. Pro2col is Herbalife's next-generation, digital, personalized health and wellness operating system, designed to drive daily engagement, sustainable behavior change, and measurable outcomes through a structured, data-driven approach to wellness. This press release features multimedia. View the full release here: https://www.bus

    2/18/26 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife to Announce Fourth Quarter and Full-Year 2025 Results on February 18

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its fourth quarter and full-year 2025 financial results after the close of trading on the NYSE on Wednesday, February 18, 2026. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/si6puiij Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server

    1/5/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife to Announce Third Quarter 2025 Results on November 5

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its third quarter 2025 financial results after the close of trading on the NYSE on Wednesday, November 5, 2025. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/4btutrtf Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BI

    10/1/25 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Reports Q2 Net Sales Near Guidance Midpoint; Q2 Adjusted EBITDA1 Exceeds Guidance; Raises Net Sales and Adjusted EBITDA1 Full-Year Guidance

    Highlights MultiBurn™ Launch and Unveiling of Beta Version of Pro2col App and Healthy Lifespan Supplement Herbalife Ltd. (NYSE:HLF) today reported financial results for the second quarter ended June 30, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806517228/en/ "Herbalife is entering a pivotal new era. The beta release of our AI-assisted Pro2col™ app at our North America Extravaganza, with over 7,000 distributors joining this early access phase, marks a bold and powerful first step." - Stephan Gratziani, CEO Highlights Second Quarter 2025 Net sales of $1.3 billion near midpoint of guidance range Down 1.7% vs.

    8/6/25 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife to Announce Second Quarter 2025 Results on August 6

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its second quarter 2025 financial results after the close of trading on the NYSE on Wednesday, August 6, 2025. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/2syhpnp7 Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BI5

    7/1/25 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care